{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:22:33Z","timestamp":1794572553648,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/mop.0000000000000334","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T14:02:28Z","timestamp":1455976948000},"page":"250-257","source":"Crossref","is-referenced-by-count":19,"title":["Childhood skin and soft tissue infections"],"prefix":"10.1097","volume":"28","author":[{"given":"Jessica","family":"Rush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Dinulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210206","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/archinte.168.14.1585","article-title":"National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.","volume":"168","author":"Hersh","year":"2008","journal-title":"Arch Intern Med"},{"key":"R2-20-20210206","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5811\/westjem.2014.4.20583","article-title":"Clinical management of skin and soft tissue infections in the U.S. Emergency departments.","volume":"15","author":"Mistry","year":"2014","journal-title":"West J Emerg Med"},{"key":"R3-20-20210206","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jiph.2013.04.010","article-title":"Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.","volume":"6","author":"Meddles-Torres","year":"2013","journal-title":"J Infect Public Health"},{"key":"R5-20-20210206","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/acem.12148","article-title":"Emergency ultrasound-assisted examination of skin and soft tissue infections in the pediatric emergency department.","volume":"20","author":"Marin","year":"2013","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"key":"R6-20-20210206","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R7-20-20210206","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/INF.0000000000000768","article-title":"Blood cultures are not useful in the evaluation of children with uncomplicated superficial skin and soft tissue infections.","volume":"34","author":"Trenchs","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20-20210206","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-4362.2003.01647.x","article-title":"Impetigo: an update.","volume":"42","author":"Brown","year":"2003","journal-title":"Int J Dermatol"},{"key":"R10-20-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/abd1806-4841.20142283","article-title":"Impetigo: review.","volume":"89","author":"Pereira","year":"2014","journal-title":"Ann Bras Dermatol"},{"key":"R11-20-20210206","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/IAI.00872-10","article-title":"Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus.","volume":"79","author":"Kato","year":"2011","journal-title":"Infect Immun"},{"key":"R12-20-20210206","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2133.2010.09655.x","article-title":"Community-associated methicillin-resistant Staphylococcus aureus and impetigo.","volume":"162","author":"Del Giudice","year":"2010","journal-title":"Br J Dermatol"},{"key":"R13-20-20210206","first-page":"CD003261","article-title":"Interventions for impetigo.","volume":"1","author":"Koning","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20-20210206","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/AAC.00079-15","article-title":"High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.","volume":"59","author":"Antonov","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-20-20210206","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/AAC.02707-13","article-title":"Decreased susceptibilities to retapamulin, mupirocin, and chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.","volume":"58","author":"McNeil","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-20-20210206","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/jac\/dkv169","article-title":"Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA.","volume":"70","author":"Poovelikunnel","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R17-20-20210206","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-4632.2012.05747.x","article-title":"Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance.","volume":"52","author":"Heng","year":"2013","journal-title":"Int J Dermatol"},{"key":"R18-20-20210206","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/fmb.14.78","article-title":"Ozenoxacin 1 cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial.","volume":"9","author":"Gropper","year":"2014","journal-title":"Future Microbiol"},{"key":"R19-20-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5114\/pdia.2014.40957","article-title":"The effect of clary sage oil on staphylococci responsible for wound infections.","volume":"32","author":"Sienkiewicz","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"R20-20-20210206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation.","volume":"89","author":"Jeng","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"R21-20-20210206","doi-asserted-by":"crossref","first-page":"e959","DOI":"10.1542\/peds.2008-2428","article-title":"Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.","volume":"123","author":"Elliott","year":"2009","journal-title":"Pediatrics"},{"key":"R22-20-20210206","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial.","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R23-20-20210206","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3928\/00904481-20100922-02","article-title":"MRSA, staphylococcal scalded skin syndrome, and other cutaneous bacterial emergencies.","volume":"39","author":"Berk","year":"2010","journal-title":"Pediatr Ann"},{"key":"R24-20-20210206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/pde.12195","article-title":"Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome.","volume":"31","author":"Braunstein","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R25-20-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/pde.12114","article-title":"Staphylococcal scalded skin syndrome in neonates: an 8-year retrospective study in a single institution.","volume":"31","author":"Li","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R26-20-20210206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.annemergmed.2009.03.014","article-title":"Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient.","volume":"55","author":"Duong","year":"2010","journal-title":"Ann Emerg Med"},{"key":"R27-20-20210206","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annemergmed.2010.03.002","article-title":"Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection.","volume":"56","author":"Schmitz","year":"2010","journal-title":"Ann Emerg Med"},{"key":"R28-20-20210206","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/fampra\/cmt075","article-title":"Epidemiology of molluscum contagiosum in children: a systematic review.","volume":"31","author":"Olsen","year":"2014","journal-title":"Fam Pract"},{"key":"R29-20-20210206","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1542\/peds.2011-1054","article-title":"Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children.","volume":"129","author":"Netchiporouk","year":"2012","journal-title":"Pediatrics"},{"key":"R31-20-20210206","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-1470.2012.01810.x","article-title":"Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.","volume":"31","author":"Coloe Dosal","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R32-20-20210206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/dth.12105","article-title":"Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.","volume":"26","author":"Moye","year":"2013","journal-title":"Dermatol Ther"},{"key":"R33-20-20210206","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pde.12518","article-title":"The utility of cantharidin for the treatment of molluscum contagiosum.","volume":"32","author":"Osier","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R35-20-20210206","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/pde.12276","article-title":"Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.","volume":"31","author":"Moye","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R36-20-20210206","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/2229-5178.153005","article-title":"A comparative study of 10 KOH solution and 5 imiquimod cream for the treatment of Molluscum contagiosum in the pediatric age group.","volume":"6","author":"Chathra","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"R37-20-20210206","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09546634.2013.832135","article-title":"Comparison of 10 potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial.","volume":"25","author":"Handjani","year":"2014","journal-title":"J Dermatol Treat"},{"key":"R38-20-20210206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamadermatol.2014.3335","article-title":"Dermatologists, imiquimod, and treatment of molluscum contagiosum in children: righting wrongs.","volume":"151","author":"Katz","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R39-20-20210206","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/pde.12504","article-title":"Molluscum contagiosum: to treat or not to treat Experience with 170 children in an outpatient clinic setting in the northeastern United States.","volume":"32","author":"Basdag","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R40-20-20210206","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/pde.12113","article-title":"Human papillomavirus (HPV) genotyping of cutaneous warts in Greek children.","volume":"30","author":"Giannaki","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R41-20-20210206","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2340\/00015555-2111","article-title":"Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children.","volume":"95","author":"Abeck","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R42-20-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/pde.12387","article-title":"Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.","volume":"32","author":"Pandey","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"R43-20-20210206","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/pde.12584","article-title":"Children with warts: a retrospective study in an outpatient setting.","volume":"32","author":"Kuwabara","year":"2015","journal-title":"Pediatr Dermatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:30:39Z","timestamp":1620963039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201604000-00020"}},"subtitle":["new discoveries and guidelines regarding the management of bacterial soft tissue infections, molluscum contagiosum, and warts"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000334","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}